Auf dieser Seite
01ILMN Preis
02Momentaufnahme
03Chart
04Aktiensplits
05Über uns
06Performance
07Bewertung & Kennzahlen
14Erträge
15Vollständige Fundamentaldaten
16Erklärungen
17Institutionelle Eigentümer (13F)
18Aktivisten & 5%+-Eigentümer
19Unternehmensinsider
20ETF-Besitz
21Konsens
22Peers
23Nachrichten
25Handelssignale
26Meine Kennzahlen
ILMN Illumina, Inc. - Common Stock
NASDAQ · Life Sciences Tools & Services · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Jul 31, 2026
$273,04
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$88,0052-Wochen-Tief
$280,1752-Wochen-Hoch
Marktkapitalisierung (MRQ)
$54.88B
P/E (TTM)
50.9
EPS (TTM)
$5.36
Umsatz (TTM)
$4.49B
Ihre Abzeichen
52W-Spanne
$88–$280
Analystenbewertung
BUY
Kursziel
$203
P/E
50.9
ROE
32.4%
Nettogewinnmarge
18.4%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
ILMN Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$273.04
Marktkapitalisierung (MRQ)
$54.88B
P/E (TTM)
50.9
EPS (TTM)
$5.36
Umsatz (TTM)
$4.49B
ROE (TTM)
32.4%
Verschuldungsgrad (MRQ)
0.2
52W-Spanne
$88–$280
ILMN Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 25. Juni 2024 | 257-for-250 | Vorwärts |
| 23. September 2008 | 2-for-1 | Vorwärts |
Über Illumina, Inc. - Common Stock Unternehmensübersicht von Wikipedia
Illumina ist ein US-amerikanischer Hersteller von Geräten für die Gentechnik mit Sitz in San Diego. Das Unternehmen wurde 1998 gegründet und ging im Jahr 2000 an die Börse. llumina besitzt einen Marktanteil von 71 % bei Sequenzierautomaten. Die Sequenzierer detektieren, wie die Sanger-Sequenzierung, mittels sequencing-by-synthesis (SBS).
## Geschichte
Von 1999 bis Ende 2016 wurde Illumina von Jay Flatley geleitet, welcher nach seinem Abgang als CEO noch bis 2021 als Executive Chairman arbeitete.
2007 übernahm Illumina die Firma Solexa. Bei Solexa wurde die Solexa/Illumina DNA-Sequenzierungsmethode entwickelt (von David Klenerman und Shankar Balasubramanian, die 1998 Solexa gründeten). 2006 übernahm Illumina Solexa für 600 Millionen Dollar.
Im September 2022 hat die EU-Kommission die Übernahme des Krebstestentwicklers Grail durch Illumina verboten, um den Wettbewerb zwischen den Entwicklern von Krebsfrüherkennungstests zu bewahren. Dies nachdem die Übernahme im August 2021 bereits vollzogen worden war. Grail war 2016 von Illumina gegründet worden, die mit 14,6 % der größte Aktionär des Unternehmens blieb. Zu den Mitbesitzern gehörten Jeff Bezos und Bill Gates.
== Einzelnachweise ==
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
SektorHealthcare
BrancheLife Sciences Tools & Services
Mitarbeiter8.600
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$4.34B2017-01-01 → 2025-12-28
EPS$5.452017-01-01 → 2025-12-28
Freier Cashflow$931M2017-01-01 → 2025-12-28
Nettogewinnmarge18.4%2017-01-01 → 2025-12-28
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | ILMN | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 50.95-Jahres-Durchschnitt ≈11.0 | ≈11.0 | 31.1 | Überbewertet | |
| P/S (TTM) | 12.25-Jahres-Durchschnitt ≈6.8 | ≈6.8 | 5.4 | Überbewertet | |
| K/B (MRQ) | 19.35-Jahres-Durchschnitt ≈6.1 | ≈6.1 | 6.9 | Überbewertet | |
| Kurs / FCF (TTM) | 58.95-Jahres-Durchschnitt ≈118.8 | ≈118.8 | · | · | |
| Kurs / Cashflow (TTM) | 50.15-Jahres-Durchschnitt ≈55.2 | ≈55.2 | 25.7 | Unterbewertet | |
| Kurs / Materieller Buchwert (MRQ) | 22.65-Jahres-Durchschnitt ≈141.9 | ≈141.9 | · | · | |
| PEG Ratio (PEG-Ratio) | ≈12.3 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | ILMN | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 66.4%5-Jahres-Durchschnitt ≈65.4% | ≈65.4% | 57.6% | Spitzenklasse | |
| Betriebsgewinnmarge (TTM) | 19.7%5-Jahres-Durchschnitt ≈-23.6% | ≈-23.6% | 18.0% | Spitzenklasse | |
| EBITDA Margin (EBITDA-Marge) | 24.8%5-Jahres-Durchschnitt ≈-16.0% | ≈-16.0% | 18.6% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | 22.6%5-Jahres-Durchschnitt ≈-20.4% | ≈-20.4% | 18.9% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | 18.4%5-Jahres-Durchschnitt ≈-22.7% | ≈-22.7% | 15.8% | Spitzenklasse | |
| ROA (TTM) | 13.0%5-Jahres-Durchschnitt ≈-7.5% | ≈-7.5% | 11.5% | Im Einklang | |
| ROE (TTM) | 32.4%5-Jahres-Durchschnitt ≈-19.8% | ≈-19.8% | 18.4% | Spitzenklasse | |
| ROIC | 19.6%5-Jahres-Durchschnitt ≈-18.1% | ≈-18.1% | 13.8% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | ILMN | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.25-Jahres-Durchschnitt ≈0.1 | ≈0.1 | 0.2 | Im Einklang | |
| Liquiditätsgrad (MRQ) | 1.85-Jahres-Durchschnitt ≈1.9 | ≈1.9 | 1.6 | Starke Liquidität | |
| Quick Ratio | 0.75-Jahres-Durchschnitt ≈0.5 | ≈0.5 | 0.7 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | ILMN | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -0.66%5-Jahres-Durchschnitt ≈7.1% | ≈7.1% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -1.8%5-Jahres-Durchschnitt ≈2.9% | ≈2.9% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 6.0% | · | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | 4.1% | · | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | 5.3% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | ILMN | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.75-Jahres-Durchschnitt ≈0.5 | ≈0.5 | 0.6 | Im Einklang | |
| Inventory Turnover (Lagerumschlag) | 2.75-Jahres-Durchschnitt ≈3.0 | ≈3.0 | 3.3 | Schwach | |
| Receivables Turnover (Forderungsumschlag) | 5.55-Jahres-Durchschnitt ≈6.6 | ≈6.6 | 5.5 | Im Einklang | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$505.0K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
8.0%
Nächster Bericht
Okt 28, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Jul 29, 2026 | $1.31 | $1.25 | 4.7% |
| 31. März 2026 | $1.15 | $1.08 | 6.9% | |
| 31. Dezember 2025 | $1.15 | $1.08 | 6.9% | |
| 30. September 2025 | $1.34 | $1.19 | 12.7% | |
| 30. Juni 2025 | $1.19 | $1.03 | 15.3% | |
| 31. März 2025 | $0.97 | $0.96 | 1.3% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.34B | $4.37B | $4.50B | $4.58B | $4.53B | $3.24B | $3.54B | $3.33B | $2.75B | $2.40B | $2.22B | $1.86B | |
| Cost of Revenue | $1.47B | $1.51B | $1.76B | $1.61B | $1.37B | $1.04B | $1.08B | $1.03B | $926M | $732M | $671M | $564M | |
| Gross Profit | $2.87B | $2.86B | $2.74B | $2.97B | $3.15B | $2.20B | $2.47B | $2.30B | $1.83B | $1.67B | $1.55B | $1.30B | |
| R&D Expense | $967M | $1.17B | $1.35B | $1.32B | $1.19B | $682M | $647M | $623M | $546M | $504M | $401M | $388M | |
| SG&A Expense | $1.09B | $1.09B | $1.61B | $1.30B | $2.09B | $941M | $835M | $794M | $674M | $584M | $516M | $466M | |
| Operating Expenses | $2.06B | $3.69B | $3.81B | $7.15B | $3.28B | $1.62B | $1.48B | $1.42B | $1.22B | $1.08B | $936M | $783M | |
| Operating Income | $807M | $-833M | $-1.07B | $-4.18B | $-123M | $580M | $985M | $883M | $606M | $587M | $613M | $515M | |
| Interest Expense | · | · | $77M | $26M | $61M | $49M | $52M | $57M | $37M | $33M | $43M | $42M | |
| Interest Income | $40M | $46M | $58M | $11M | $0 | $41M | $75M | $44M | $19M | $10M | $5M | $4M | |
| Other Non-op | $340M | $-292M | $-29M | $-142M | $1.07B | $284M | $110M | $24M | $455M | $-3M | $-8M | $-33M | |
| Pretax Income | $1.09B | $-1.18B | $-1.12B | $-4.34B | $884M | $856M | $1.12B | $894M | $1.04B | $561M | $583M | $449M | |
| Income Tax | $236M | $44M | $44M | $68M | $122M | $200M | $128M | $112M | $365M | $133M | $125M | $95M | |
| Net Income | $850M | $-1.22B | $-1.16B | $-4.40B | $762M | $656M | $1.00B | $826M | $726M | $463M | $462M | $353M | |
| EPS (Basic) | $5.47 | $-7.69 | $-7.34 | $-28.00 | $5.07 | $4.48 | $6.81 | $5.63 | $4.96 | $3.09 | $3.19 | $2.61 | |
| EPS (Diluted) | $5.45 | $-7.69 | $-7.34 | $-28.00 | $5.04 | $4.45 | $6.74 | $5.56 | $4.92 | $3.07 | $3.10 | $2.37 | |
| Shares (Basic) | 155,000,000 | 159,000,000 | 158,000,000 | 157,000,000 | 150,000,000 | 147,000,000 | 147,000,000 | 147,000,000 | 146,000,000 | 147,000,000 | 145,000,000 | 135,553,000 | |
| Shares (Diluted) | 156,000,000 | 159,000,000 | 158,000,000 | 157,000,000 | 151,000,000 | 148,000,000 | 149,000,000 | 149,000,000 | 148,000,000 | 148,000,000 | 149,000,000 | 148,977,000 | |
| EBITDA | $1.08B | $-479M | $-637M | $-3.79B | $128M | $767M | $1.17B | $1.06B | $762M | $729M | $613M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | · | $1.14B | $1.23B | $735M | $769M | $636M | |
| Short-term Investments | $215M | $93M | $6M | $26M | $107M | $1.66B | $1.37B | $2.37B | $920M | $824M | $617M | $702M | |
| Receivables | $854M | $735M | $734M | $671M | $648M | $487M | $573M | $514M | $411M | $381M | $386M | $289M | |
| Inventory | $564M | $547M | $587M | $568M | $431M | $372M | $359M | $386M | $333M | $300M | $271M | $191M | |
| Prepaid Expense | $238M | $244M | $234M | $285M | $295M | $152M | $105M | $78M | $91M | $78M | $54M | $30M | |
| Current Assets | $3.29B | $2.75B | $2.61B | $3.56B | $2.71B | $4.48B | $4.45B | $4.49B | $2.98B | $2.32B | $2.10B | $1.89B | |
| PP&E (Net) | $759M | $815M | $1.01B | $1.09B | $1.02B | $922M | $889M | $1.07B | $931M | $713M | $343M | $265M | |
| PP&E (Gross) | $2.12B | $2.07B | $2.15B | $2.05B | $1.82B | $1.60B | $1.46B | $1.60B | $1.35B | $1.04B | $609M | $480M | |
| Accum. Depreciation | $1.36B | $1.25B | $1.14B | $962M | $796M | $678M | $568M | $521M | $416M | $327M | $267M | $215M | |
| Goodwill | $1.11B | $1.11B | $2.54B | $3.24B | $7.11B | $897M | $897M | $831M | $771M | $776M | $753M | $725M | |
| Intangibles | $210M | $295M | $2.99B | $3.29B | $3.25B | $142M | $145M | $185M | $175M | $243M | $274M | $314M | |
| Other Non-current Assets | $449M | $348M | $357M | $423M | $445M | $609M | $388M | $308M | $312M | $108M | $87M | $96M | |
| Total Assets | $6.64B | $6.30B | $10.11B | $12.25B | $15.22B | $7.58B | $7.32B | $6.96B | $5.26B | $4.28B | $3.69B | $3.34B | |
| Accounts Payable | $240M | $221M | $245M | $293M | $332M | $192M | $149M | $184M | $160M | $138M | $139M | $83M | |
| Accrued Liabilities | $846M | $827M | $1.32B | $1.23B | $761M | $541M | $516M | $513M | $432M | $342M | $387M | $335M | |
| Short-term Debt | $499M | $499M | $0 | $500M | $0 | · | · | · | · | · | · | · | |
| Current Liabilities | $1.58B | $1.55B | $1.57B | $2.77B | $1.09B | $1.24B | $665M | $1.80B | $746M | $705M | $610M | $722M | |
| Capital Leases | $486M | $554M | $687M | $744M | $774M | $671M | $695M | · | · | · | · | · | |
| Other Non-current Liabilities | $360M | $339M | $620M | $649M | $915M | $303M | $202M | $359M | $360M | $206M | $181M | $168M | |
| Long-term Debt | · | · | · | · | · | $1.18B | $1.14B | $2.00B | $1.19B | $1.06B | $1.09B | $1.29B | |
| Total Debt | $499M | $499M | $0 | $500M | · | $1.18B | $1.14B | $2.00B | $1.19B | $1.05B | $1.09B | · | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Paid-in Capital | $7.82B | $7.53B | $9.55B | $9.21B | $8.94B | $3.81B | $3.56B | $3.29B | $2.83B | $2.73B | $2.50B | $2.17B | |
| Retained Earnings | $-392M | $-1.24B | $-19M | $1.14B | $5.49B | $4.72B | $4.07B | $3.08B | $2.26B | $1.49B | $1.02B | $561M | |
| Treasury Stock | $4.70B | $3.93B | $3.79B | $3.75B | $3.70B | $3.85B | $3.02B | $2.62B | $2.34B | $2.02B | $1.67B | $1.27B | |
| AOCI | $-10M | $22M | $-1M | $3M | $17M | $2M | $5M | $-1M | $-1M | $-1M | $36.0K | $-1M | |
| Stockholders' Equity | $2.72B | $2.37B | $5.75B | $6.60B | $10.74B | $4.69B | $4.61B | $3.85B | $2.75B | $2.20B | $1.85B | $1.46B | |
| Liabilities + Equity | $6.64B | $6.30B | $10.11B | $12.25B | $15.22B | $7.58B | $7.32B | $6.96B | $5.26B | $4.28B | $3.69B | $3.34B | |
| Shares Outstanding | 201,000,000 | 200,000,000 | 199,000,000 | 198,000,000 | 197,000,000 | 195,000,000 | 147,000,000 | 147,000,000 | 147,000,000 | 146,000,000 | 146,584,000 | 143,629,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $270M | $354M | $432M | $394M | $251M | $187M | $188M | $179M | $156M | $141M | $127M | $113M | |
| Stock-based Comp | $275M | $370M | $380M | $366M | $754M | $194M | $194M | $193M | $164M | $129M | $133M | $153M | |
| Deferred Tax | $119M | $-117M | $-34M | $-23M | $-76M | $117M | $5M | $-18M | $34M | $7M | $-45M | $-20M | |
| Amort. of Intangibles | $67M | $130M | $197M | $179M | $75M | $31M | $37M | $39M | $46M | $51M | $54M | $51M | |
| Restructuring | $47M | $16M | $52M | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-435M | $1.45B | $861M | $4.06B | $-1.15B | $-74M | $-338M | $-38M | $-205M | $-53M | · | · | |
| Operating Cash Flow | $1.08B | $837M | $478M | $392M | $545M | $1.08B | $1.05B | $1.14B | $875M | $779M | $786M | $501M | |
| CapEx | $148M | $128M | $195M | $286M | $208M | $189M | $209M | $296M | $310M | $260M | $143M | $106M | |
| Investing Cash Flow | $-55M | $-178M | $-231M | $-591M | $-1.07B | $-554M | $745M | $-1.81B | $-214M | $-515M | $-107M | $-407M | |
| Debt Issued | $495M | $1.24B | $0 | $991M | $988M | $0 | $0 | $735M | $5M | $5M | · | $1.13B | |
| Net Debt Issued | $495M | $1.24B | $0 | $991M | $988M | $0 | $0 | $735M | $5M | $5M | · | · | |
| Stock Issued | $44M | $56M | $67M | $63M | $60M | $61M | $59M | $46M | $71M | $47M | $72M | $96M | |
| Stock Repurchased | $742M | $116M | $0 | $0 | $0 | $736M | $324M | $201M | $251M | $249M | $274M | $237M | |
| Net Stock Activity | $-698M | $-60M | $67M | $63M | $60M | $-675M | $-265M | $-155M | $-180M | $-202M | $-202M | · | |
| Financing Cash Flow | $-744M | $-570M | $-1.21B | $1.00B | $-51M | $-766M | $-897M | $594M | $-176M | $-296M | $-545M | $-167M | |
| Net Change in Cash | $291M | $79M | $-963M | $779M | $-578M | $-232M | $898M | $-81M | $490M | $-34M | $133M | $-75M | |
| Taxes Paid | $73M | $105M | $65M | $122M | $233M | $119M | $164M | $99M | $149M | $60M | $17M | $18M | |
| Free Cash Flow | $931M | $709M | $283M | $106M | $337M | $891M | $842M | $846M | $565M | $427M | $517M | · | |
| Levered FCF | · | · | $203M | $80M | $284M | $853M | $796M | $796M | $541M | $402M | $484M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 66.1% | 65.4% | 60.9% | 64.8% | 69.7% | 68.0% | 69.6% | 69.0% | 66.3% | 69.5% | 69.8% | · | |
| Operating Margin | 18.6% | -19.1% | -23.7% | -91.2% | -2.7% | 17.9% | 27.8% | 26.5% | 22.0% | 24.5% | 27.6% | · | |
| Net Margin | 19.6% | -28.0% | -25.8% | -96.1% | 16.8% | 20.2% | 28.3% | 24.8% | 26.4% | 19.3% | 20.8% | · | |
| Pretax Margin | 25.0% | -27.0% | -24.8% | -94.6% | 19.5% | 26.4% | 31.6% | 26.8% | 37.9% | 23.4% | 26.3% | · | |
| EBITDA Margin | 24.8% | -11.0% | -14.1% | -82.6% | 2.8% | 23.7% | 33.1% | 31.9% | 27.7% | 30.4% | 27.6% | · | |
| ROA | 13.1% | -14.9% | -10.4% | -32.1% | 6.7% | 8.8% | 14.0% | 13.5% | 15.2% | 11.6% | 13.1% | · | |
| ROE | 34.1% | -54.4% | -19.9% | -66.1% | 7.1% | 14.0% | 22.1% | 25.4% | 29.4% | 22.9% | 27.9% | · | |
| ROIC | 19.6% | -30.1% | -19.3% | -59.8% | -0.99% | 7.6% | 15.2% | 13.4% | 10.0% | 13.8% | 16.4% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 1.8 | 1.7 | 1.3 | 2.5 | 3.6 | 6.7 | 2.5 | 4.0 | 3.3 | 3.4 | · | |
| Quick Ratio | 0.7 | 0.5 | 0.5 | 0.3 | 0.7 | 1.7 | 2.9 | 2.2 | 3.4 | 2.8 | 2.9 | · | |
| Debt / Equity | 0.2 | 0.2 | 0.0 | 0.1 | · | 0.3 | 0.2 | 0.5 | 0.4 | 0.5 | 0.6 | · | |
| LT Debt / Equity | · | · | · | · | · | 0.1 | 0.2 | 0.2 | 0.4 | 0.5 | 0.5 | · | |
| Interest Coverage | · | · | -13.9 | -160.7 | -2.0 | 11.8 | 18.9 | 15.5 | 16.4 | 17.7 | 14.5 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.5 | 0.4 | 0.3 | 0.4 | 0.4 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | · | |
| Inventory Turnover | 2.7 | 2.7 | 3.0 | 3.2 | 3.4 | 2.8 | 2.9 | 2.9 | 2.9 | 2.6 | 2.9 | · | |
| Receivables Turnover | 5.5 | 6.0 | 6.4 | 7.0 | 8.0 | 6.1 | 6.5 | 7.2 | 6.9 | 6.3 | 6.6 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $17.80 | $14.92 | $36.13 | $41.77 | $68.41 | $32.15 | $31.38 | $25.56 | $18.70 | $15.03 | $12.61 | · | |
| Revenue / Share | $27.84 | $27.50 | $28.51 | $29.20 | $29.97 | $21.89 | $23.78 | $22.37 | $18.59 | $16.20 | $14.89 | · | |
| Cash Flow / Share | $6.92 | $5.26 | $3.03 | $2.50 | $3.61 | $7.30 | $7.05 | $7.66 | $5.91 | $4.64 | $4.42 | · | |
| Cash / Share | · | · | · | · | · | · | · | $7.78 | $8.33 | $5.02 | $5.24 | · | |
| EPS (TTM) | $5.45 | $-7.69 | $-7.34 | $-28.00 | $5.04 | $4.45 | $6.74 | $5.56 | $4.92 | $3.07 | $3.10 | $2.37 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -0.66% | -2.9% | -1.8% | 1.3% | 39.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -1.8% | -1.1% | 11.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | · | 13.3% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 4.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | · | 16.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 5.3% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.34B | $4.37B | $4.50B | $4.58B | $4.53B | $3.24B | $3.54B | $3.33B | $2.75B | $2.40B | $2.22B | $1.86B | |
| Net Income TTM | $850M | $-1.22B | $-1.16B | $-4.40B | $762M | $656M | $1.00B | $826M | $726M | $463M | $462M | $353M | |
| Market Cap | $20.65B | $21.51B | $21.54B | $31.08B | $58.10B | $52.55B | $47.52B | $42.65B | $31.24B | $18.21B | $27.37B | · | |
| Enterprise Value | · | · | · | · | · | · | · | $41.13B | $30.29B | $17.70B | $27.07B | · | |
| P/E | 24.8 | -17.6 | -18.5 | -7.0 | 73.4 | 80.9 | 48.0 | 52.2 | 43.2 | 40.6 | 60.2 | 77.2 | |
| P/S | 4.8 | 4.9 | 4.8 | 6.8 | 12.8 | 16.2 | 13.4 | 12.8 | 11.4 | 7.6 | 12.3 | · | |
| P/B | 7.6 | 9.1 | 3.7 | 4.7 | 5.4 | 11.2 | 10.3 | 11.3 | 11.4 | 8.3 | 14.8 | · | |
| P / Tangible Book | 14.7 | 22.3 | 104.0 | 414.4 | 154.1 | 14.4 | · | · | · | · | · | · | |
| P / Cash Flow | 19.1 | 25.7 | 45.1 | 79.3 | 106.6 | 48.7 | 45.2 | 37.3 | 35.7 | 26.5 | 41.5 | · | |
| P / FCF | 22.2 | 30.3 | 76.1 | 293.2 | 172.4 | 59.0 | 56.4 | 50.4 | 55.3 | 42.6 | 53.0 | · | |
| EV / EBITDA | · | · | · | · | · | · | · | 38.7 | 39.8 | 24.3 | 44.2 | · | |
| EV / FCF | · | · | · | · | · | · | · | 48.6 | 53.6 | 41.4 | 52.4 | · | |
| EV / Revenue | · | · | · | · | · | · | · | 12.3 | 11.0 | 7.4 | 12.2 | · | |
| Earnings Yield | 4.0% | -5.7% | -5.4% | -14.2% | 1.4% | 1.2% | 2.1% | 1.9% | 2.3% | 2.5% | 1.7% | 1.3% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.16B | $1.09B | $1.16B | $1.08B | $1.06B | $1.04B | $1.10B | $1.08B | $1.11B | $1.08B | $1.02B | $1.18B | $1.09B | $1.11B | |
| Cost of Revenue | $389M | $370M | $400M | $351M | $364M | $358M | $376M | $335M | $391M | $409M | $476M | $444M | $432M | $480M | |
| Gross Profit | $770M | $721M | $759M | $733M | $695M | $683M | $728M | $745M | $721M | $667M | $542M | $732M | $655M | $626M | |
| R&D Expense | $252M | $240M | $239M | $229M | $247M | $252M | $252M | $253M | $325M | $339M | $332M | $358M | $341M | $474M | |
| SG&A Expense | $273M | $272M | $308M | $277M | $234M | $267M | $267M | $239M | $147M | $439M | $464M | $462M | $378M | $205M | |
| Operating Expenses | $525M | $512M | $557M | $506M | $481M | $519M | $554M | $4M | $2.36B | $778M | $1.64B | $820M | $719M | $4.60B | |
| Operating Income | $245M | $209M | $202M | $227M | $214M | $164M | $174M | $741M | $-1.64B | $-111M | $-1.10B | $-88M | $-64M | $-3.98B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $18M | · | $19M | $20M | · | |
| Interest Income | $8M | $11M | $10M | $9M | $10M | $11M | $10M | $11M | $13M | $12M | $24M | $17M | $17M | $9M | |
| Other Non-op | $31M | $-39M | $192M | $9M | $107M | $32M | $28M | $4M | $-332M | $8M | $19M | $1M | $-11M | $-45M | |
| Pretax Income | $260M | $157M | $378M | $220M | $306M | $182M | $186M | $720M | $-1.98B | $-109M | $-1.09B | $-89M | $-78M | $-4.01B | |
| Income Tax | $53M | $23M | $44M | $70M | $71M | $51M | $0 | $15M | $12M | $17M | $-74M | $145M | $-81M | $94M | |
| Net Income | $207M | $134M | $334M | $150M | $235M | $131M | $186M | $705M | $-1.99B | $-126M | $-791M | $-234M | $3M | $-4.10B | |
| EPS (Basic) | $1.37 | $0.88 | $2.17 | $0.98 | $1.49 | $0.83 | $1.15 | $4.43 | $-12.48 | $-0.79 | $-6.43 | $-1.48 | $0.02 | $-26.16 | |
| EPS (Diluted) | $1.35 | $0.87 | $2.16 | $0.98 | $1.49 | $0.82 | $1.16 | $4.42 | $-12.48 | $-0.79 | $-6.43 | $-1.48 | $0.02 | $-26.15 | |
| Shares (Basic) | 151,000,000 | 153,000,000 | · | 153,000,000 | 157,000,000 | 159,000,000 | · | 159,000,000 | 159,000,000 | 159,000,000 | · | 158,000,000 | 158,000,000 | · | |
| Shares (Diluted) | 153,000,000 | 154,000,000 | · | 154,000,000 | 157,000,000 | 159,000,000 | · | 160,000,000 | 159,000,000 | 159,000,000 | · | 158,000,000 | 158,000,000 | · | |
| EBITDA | $245M | $209M | · | $294M | $282M | $233M | · | $741M | $-1.64B | $-111M | · | $-88M | $-64M | · |
Bilanz
| Kennzahl | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Short-term Investments | $128M | $66M | $215M | $228M | $221M | $124M | $93M | $70M | $74M | · | · | $6M | $24M | · | |
| Receivables | $764M | $738M | $854M | $729M | $701M | $699M | $735M | $699M | $641M | $635M | · | $741M | $665M | · | |
| Inventory | $629M | $611M | $564M | $590M | $575M | $537M | $547M | $574M | $561M | $584M | · | $617M | $586M | · | |
| Prepaid Expense | $273M | $234M | $238M | $199M | $210M | $200M | $244M | $161M | $263M | $256M | · | $306M | $403M | · | |
| Current Assets | $2.83B | $2.74B | $3.29B | $2.80B | $2.64B | $2.67B | $2.75B | $2.37B | $2.46B | $2.58B | · | $3.22B | $3.17B | · | |
| PP&E (Net) | $745M | $755M | $759M | $748M | $764M | $782M | $815M | $832M | $859M | $964M | · | $1.07B | $1.08B | · | |
| PP&E (Gross) | · | · | $2.12B | · | · | · | $2.07B | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $1.36B | · | · | · | $1.25B | · | · | · | · | · | · | · | |
| Goodwill | $1.28B | $1.28B | $1.11B | $1.11B | $1.11B | $1.11B | $1.11B | $1.11B | $1.08B | $2.54B | $2.54B | $3.24B | $3.24B | $3.24B | |
| Intangibles | $410M | $430M | $210M | $225M | $238M | $278M | $295M | $305M | $278M | $2.94B | · | $3.19B | $3.24B | · | |
| Other Non-current Assets | $576M | $523M | $449M | $423M | $400M | $373M | $348M | $321M | $314M | $458M | · | $417M | $423M | · | |
| Total Assets | $6.65B | $6.56B | $6.64B | $6.18B | $6.09B | $6.18B | $6.30B | $6.01B | $6.08B | $10.04B | · | $11.77B | $11.81B | · | |
| Accounts Payable | $230M | $218M | $240M | $218M | $200M | $207M | $221M | $191M | $199M | $201M | · | $244M | $242M | · | |
| Accrued Liabilities | $848M | $849M | $846M | $746M | $762M | $734M | $827M | $784M | $1.26B | $1.27B | · | $1.31B | $1.24B | · | |
| Short-term Debt | $500M | $499M | $499M | $998M | $499M | $499M | $499M | · | $744M | · | · | $0 | $0 | · | |
| Current Liabilities | $1.58B | $1.57B | $1.58B | $1.96B | $1.46B | $1.44B | $1.55B | $975M | $2.21B | $1.47B | · | $2.30B | $2.23B | · | |
| Capital Leases | $454M | $475M | $486M | $506M | $528M | $539M | $554M | $613M | $616M | $700M | · | $726M | $747M | · | |
| Other Non-current Liabilities | $289M | $352M | $360M | $334M | $348M | $344M | $339M | $313M | $331M | $642M | · | $702M | $654M | · | |
| Total Debt | $500M | $499M | · | $998M | $499M | $499M | · | · | $744M | · | · | · | · | · | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | · | |
| Paid-in Capital | $7.93B | $7.86B | $7.82B | $7.76B | $7.68B | $7.61B | $7.53B | $7.45B | $7.35B | $9.66B | · | $9.40B | $9.31B | · | |
| Retained Earnings | $-51M | $-258M | $-392M | $-726M | $-876M | $-1.11B | $-1.24B | $-1.43B | $-2.13B | $-145M | · | $911M | $1.15B | · | |
| Treasury Stock | $5.05B | $4.93B | $4.70B | $4.64B | $4.52B | $4.14B | $3.93B | $3.89B | $3.79B | $3.79B | · | $3.77B | $3.76B | · | |
| AOCI | $8M | $1M | $-10M | $-12M | $-21M | $8M | $22M | $-5M | $14M | $12M | · | $12M | $-1M | · | |
| Stockholders' Equity | $2.84B | $2.68B | $2.72B | $2.38B | $2.26B | $2.37B | $2.37B | $2.12B | $1.44B | $5.73B | $5.75B | $6.55B | $6.69B | $6.60B | |
| Liabilities + Equity | $6.65B | $6.56B | $6.64B | $6.18B | $6.09B | $6.18B | $6.30B | $6.01B | $6.08B | $10.04B | · | $11.77B | $11.81B | · | |
| Shares Outstanding | 201,000,000 | 201,000,000 | 153,000,000 | 201,000,000 | 201,000,000 | 201,000,000 | 159,000,000 | 199,000,000 | 199,000,000 | 199,000,000 | 199,000,000 | 198,000,000 | 198,000,000 | 198,000,000 |
Cashflow
| Kennzahl | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $66M | $67M | $68M | $69M | $71M | $70M | $105M | $108M | · | · | · | $232M | |
| Stock-based Comp | $73M | $60M | $63M | $70M | $69M | $73M | $79M | $83M | $112M | $96M | $94M | · | $93M | $100M | |
| Amort. of Intangibles | $19M | $18M | $16M | $17M | $17M | $17M | $17M | $17M | $47M | $49M | $57M | $49M | $50M | $112M | |
| Restructuring | · | · | $6M | $2M | $8M | $31M | $2M | $6M | $4M | $4M | · | $26M | · | · | |
| Other Non-cash | · | · | · | · | · | $-33M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $201M | $289M | $321M | $284M | $234M | $240M | $364M | $316M | $80M | $77M | $224M | · | $10M | $147M | |
| CapEx | $40M | $38M | $55M | $31M | $30M | $32M | $29M | $32M | $31M | $36M | $51M | · | $52M | $88M | |
| Investing Cash Flow | $-122M | $-366M | $108M | $-51M | $-49M | $-63M | $-48M | $-41M | $-41M | $-48M | $-85M | · | $-56M | $-102M | |
| Debt Issued | · | · | $495M | · | · | · | $0 | · | · | · | · | · | · | $3M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | $-500M | · | |
| Stock Issued | $0 | $24M | $0 | $16M | $1M | $27M | $0 | $20M | $0 | $36M | $0 | · | $37M | $0 | |
| Stock Repurchased | $128M | $242M | $42M | $130M | $370M | $200M | $17M | $99M | $0 | $0 | $0 | · | · | $0 | |
| Net Stock Activity | · | $-218M | · | · | · | $-173M | · | · | · | $36M | · | · | $37M | · | |
| Financing Cash Flow | $-129M | $-251M | $-63M | $-115M | $-371M | $-195M | $-47M | $-332M | $-226M | $35M | $-27M | · | $-473M | $956M | |
| Net Change in Cash | $-49M | $-329M | $368M | $116M | $-179M | $-14M | $258M | $-51M | $-188M | $60M | $121M | · | $-517M | $1.01B | |
| Free Cash Flow | · | $251M | · | · | · | $208M | · | · | · | $41M | · | · | $-42M | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $20M | · | · | $-41M | · |
Rentabilität
| Kennzahl | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 66.4% | 66.1% | · | 67.6% | 65.6% | 65.6% | · | 69.0% | 64.8% | 62.0% | · | 62.2% | 60.3% | · | |
| Operating Margin | 21.1% | 19.2% | · | 20.9% | 20.2% | 15.8% | · | 68.6% | -147.2% | -10.3% | · | -7.5% | -5.9% | · | |
| Net Margin | 17.9% | 12.3% | · | 13.8% | 22.2% | 12.6% | · | 65.3% | -178.8% | -11.7% | · | -19.9% | 0.28% | · | |
| Pretax Margin | 22.4% | 14.4% | · | 20.3% | 28.9% | 17.5% | · | 66.7% | -177.7% | -10.1% | · | -7.6% | -7.2% | · | |
| EBITDA Margin | 21.1% | 19.2% | · | 27.1% | 26.6% | 22.4% | · | 68.6% | -147.2% | -10.3% | · | -7.5% | -5.9% | · | |
| ROA | 3.2% | 2.1% | · | 2.5% | 3.9% | 1.6% | · | 8.7% | -22.3% | -1.1% | · | · | · | · | |
| ROE | 8.1% | 5.3% | · | 6.7% | 12.7% | 3.2% | · | 17.6% | -49.8% | -2.0% | · | · | · | · | |
| ROIC | 5.8% | 5.6% | · | 4.6% | 6.0% | 4.1% | · | 34.1% | -75.5% | -2.2% | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 1.7 | · | 1.4 | 1.8 | 1.9 | · | 2.4 | 1.1 | 1.8 | · | · | · | · | |
| Quick Ratio | 0.6 | 0.5 | · | 0.5 | 0.6 | 0.6 | · | 0.8 | 0.3 | 0.4 | · | · | · | · | |
| Debt / Equity | 0.2 | 0.2 | · | 0.4 | 0.2 | 0.2 | · | · | 0.5 | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -6.2 | · | -4.6 | -3.2 | · |
Effizienz
| Kennzahl | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | · | · | · | |
| Inventory Turnover | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.7 | 0.7 | · | · | · | · | |
| Receivables Turnover | 1.6 | 1.5 | · | 1.5 | 1.6 | 1.6 | · | 1.6 | 1.6 | 1.7 | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $14.12 | $13.31 | · | $11.85 | $11.23 | $11.78 | · | $10.68 | $7.22 | $28.81 | · | · | · | · | |
| Revenue / Share | $7.58 | $7.08 | · | $7.04 | $6.75 | $6.55 | · | $6.75 | $6.99 | $6.77 | · | $7.44 | $6.88 | · | |
| Cash Flow / Share | · | $1.88 | · | · | · | $1.51 | · | · | · | $0.48 | · | · | $0.06 | · | |
| EPS (TTM) | $5.36 | $5.50 | · | $4.45 | $7.89 | $-6.08 | · | $-15.28 | $-24.47 | $-13.47 | · | $-51.87 | · | $-28.00 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.49B | $4.39B | · | $4.29B | $4.28B | $4.34B | · | $4.29B | $4.33B | $4.39B | · | $4.48B | · | $4.58B | |
| Net Income TTM | $825M | $853M | · | $702M | $1.26B | $-966M | · | $-2.20B | $-3.66B | $-1.91B | · | · | · | $-4.40B | |
| Market Cap | $35.49B | $23.65B | · | $18.43B | $19.05B | $16.08B | · | $25.89B | $20.77B | $26.58B | · | · | · | · | |
| P/E | 32.9 | 21.4 | · | 20.6 | 12.0 | -13.2 | · | -8.5 | -4.3 | -9.9 | · | -3.5 | · | -7.0 | |
| P/S | 7.9 | 5.4 | · | 4.3 | 4.4 | 3.7 | · | 6.0 | 4.8 | 6.1 | · | · | · | · | |
| P/B | 12.5 | 8.8 | · | 7.7 | 8.4 | 6.8 | · | 12.2 | 14.5 | 4.6 | · | · | · | · | |
| P / Tangible Book | 31.0 | 24.6 | · | 17.7 | 21.0 | 16.5 | · | 36.6 | 262.9 | 106.8 | · | · | · | · | |
| P / Cash Flow | · | 81.8 | · | · | · | 67.0 | · | · | · | 345.2 | · | · | · | · | |
| Earnings Yield | 3.0% | 4.7% | · | 4.9% | 8.3% | -7.6% | · | -11.7% | -23.4% | -10.1% | · | -28.4% | · | -14.2% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-28 | 2024-12-29 | 2023-12-31 | 2023-01-01 | 2022-01-02 |
|---|---|---|---|---|---|
| Umsatz | $4.34B | $4.37B | $4.50B | $4.58B | $4.53B |
| Bruttogewinnmarge % | 66.1% | 65.4% | 60.9% | 64.8% | 69.7% |
| Betriebsgewinnmarge % | 18.6% | -19.1% | -23.7% | -91.2% | -2.7% |
| Nettoergebnis | $850M | $-1.22B | $-1.16B | $-4.40B | $762M |
| Verwässerte EPS | $5.45 | $-7.69 | $-7.34 | $-28.00 | $5.04 |
| Kennzahl | 2025-12-28 | 2024-12-29 | 2023-12-31 | 2023-01-01 | 2022-01-02 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.2 | 0.2 | 0.0 | 0.1 | · |
| Liquiditätsgrad | 2.1 | 1.8 | 1.7 | 1.3 | 2.5 |
| Quick Ratio | 0.7 | 0.5 | 0.5 | 0.3 | 0.7 |
| Kennzahl | 2025-12-28 | 2024-12-29 | 2023-12-31 | 2023-01-01 | 2022-01-02 |
|---|---|---|---|---|---|
| Freier Cashflow | $931M | $709M | $283M | $106M | $337M |
Institutionelle Eigentümer (13F) 1.001 Einreicher · $28.9B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
1.001
Gehaltener Wert
$28.9B
Neue Positionen
159
Geschlossene Positionen
60
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 159 (+37 vs. Vorquartal) | 60 (-35 vs. Vorquartal) | 300 (+12 vs. Vorquartal) | 340 (+18 vs. Vorquartal) | -665K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $3.374.423.404 | 19.191.398 | 11,68% | Aktien |
| Capital World Investors | $2.712.230.480 | 15.425.298 | 9,39% | Aktien |
| VANGUARD GROUP INC | $1.882.851.641 | 14.355.380 | 6,52% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.165.253.015 | 6.627.157 | 4,03% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.158.286.103 | 6.587.534 | 4,01% | Aktien |
| STATE STREET CORP | $1.144.176.449 | 6.507.288 | 3,96% | Aktien |
| WCM INVESTMENT MANAGEMENT, LLC | $1.124.033.551 | 6.206.701 | 3,89% | Aktien |
| FMR LLC | $795.352.414 | 4.523.417 | 2,75% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $623.223.145 | 3.544.465 | 2,16% | Aktien |
| PRIMECAP MANAGEMENT CO/CA/ | $617.980.735 | 3.514.649 | 2,14% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $516.720.645 | 2.946.669 | 1,79% | Aktien |
| Corvex Management LP | $497.695.958 | 2.830.552 | 1,72% | Aktien |
| Invesco Ltd. | $350.647.369 | 1.994.241 | 1,21% | Aktien |
| LOOMIS SAYLES & CO L P | $339.694.497 | 1.931.948 | 1,18% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $318.767.131 | 1.812.928 | 1,10% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $308.478.035 | 1.744.209 | 1,07% | Aktien |
| Bank of New York Mellon Corp | $293.845.659 | 1.671.192 | 1,02% | Aktien |
| MORGAN STANLEY | $290.939.963 | 1.654.664 | 1,01% | Aktien |
| JANUS HENDERSON GROUP PLC | $258.924.054 | 2.100.638 | 0,90% | Aktien |
| BANK OF AMERICA CORP /DE/ | $255.883.167 | 1.455.287 | 0,89% | Aktien |
| NORTHERN TRUST CORP | $251.313.642 | 1.429.299 | 0,87% | Aktien |
| AGF MANAGEMENT LTD | $239.975.422 | 1.364.815 | 0,83% | Aktien |
| BAILLIE GIFFORD & CO | $234.881.803 | 1.335.846 | 0,81% | Aktien |
| JPMORGAN CHASE & CO | $213.918.119 | 1.181.215 | 0,74% | Aktien |
| Legal & General Group Plc | $206.298.879 | 1.173.286 | 0,71% | Aktien |
| AMERIPRISE FINANCIAL INC | $201.882.586 | 1.148.102 | 0,70% | Aktien |
| Sessa Capital IM, L.P. | $196.643.700 | 1.118.374 | 0,68% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $192.684.840 | 1.563.239 | 0,67% | Aktien |
| ARK Investment Management LLC | $183.744.158 | 1.045.010 | 0,64% | Aktien |
| NORDEA INVESTMENT MANAGEMENT AB | $177.914.475 | 1.013.065 | 0,62% | Aktien |
| Senvest Management, LLC | $177.362.886 | 1.008.718 | 0,61% | Aktien |
| GOLDMAN SACHS GROUP INC | $174.524.363 | 992.574 | 0,60% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $167.266.376 | 951.296 | 0,58% | Aktien |
| Sumitomo Mitsui Trust Group, Inc. | $167.050.984 | 950.071 | 0,58% | Aktien |
| FIRST TRUST ADVISORS LP | $159.563.763 | 907.489 | 0,55% | Aktien |
| PointState Capital LP | $151.602.384 | 862.210 | 0,52% | Aktien |
| JUPITER ASSET MANAGEMENT LTD | $147.816.940 | 840.681 | 0,51% | Aktien |
| UBS Group AG | $147.790.919 | 840.533 | 0,51% | Aktien |
| LETKO, BROSSEAU & ASSOCIATES INC | $145.990.418 | 830.293 | 0,51% | Aktien |
| NORGES BANK | $145.424.246 | 827.073 | 0,50% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $145.348.463 | 826.642 | 0,50% | Aktien |
| EDMOND DE ROTHSCHILD HOLDING S.A. | $129.791.552 | 738.165 | 0,45% | Aktien |
| GUARDCAP ASSET MANAGEMENT Ltd | $128.748.557 | 740.132 | 0,45% | Aktien |
| Chevy Chase Trust Holdings, LLC | $127.952.370 | 727.705 | 0,44% | Aktien |
| Quantinno Capital Management LP | $117.941.015 | 670.767 | 0,41% | Aktien |
| VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. | $112.126.967 | 637.701 | 0,39% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $111.681.589 | 635.168 | 0,39% | Aktien |
| Amova Asset Management Americas, Inc. | $108.658.017 | 617.972 | 0,38% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $108.597.114 | 881.041 | 0,38% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $107.034.977 | 608.463 | 0,37% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Illumina, Inc. ×2 Einreichungen | 5. Februar 2007 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 88 Insider · 51 Führungskräfte · 30 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jacob Thaysen | Chief Executive Officer | 5. März 2026 A | 109.073 | 0 | 0 | $0 |
| Francis A Desouza | President and CEO | 1. März 2023 A | 120.992 | 0 | 0 | $0 |
| Ankur Dhingra | SVP, Chief Financial Officer | 5. März 2026 A | 34.264 | 0 | 0 | $0 |
| Joydeep Goswami | SVP, Chief Financial Officer | 5. März 2024 A | 24.478 | 0 | 0 | $0 |
| Sam Samad | SVP and CFO | 1. März 2022 A | 11.297 | 0 | 0 | $0 |
| Timothy M Kish | VP Finance & CFO | 2. März 2005 A | · | 0 | 0 | $0 |
| John R Stuelpnagel | Sr VP and COO | 27. März 2008 M | 337.836 | 0 | 0 | $0 |
| Julie Ann Coletti | Chief Legal Officer | 8. September 2026 A | 18.763 | 0 | 0 | $0 |
| Steven Barnard | SVP, Chief Technology Officer | 5. September 2026 F | 40.927 | 0 | 0 | $0 |
| Christensen Jakob Wedel | SVP, Strategy/Corp Development | 18. August 2026 S | 14.023 | 0 | 3 | $-366.137 |
| Scott M Davies | Chief Legal Officer | 30. Juli 2026 S | 20.338 | 0 | 5 | $-531.273 |
| Patricia Leckman | SVP, Chief People Officer | 5. Juni 2026 S | 21.259 | 0 | 9 | $-529.720 |
| Scott D Ericksen | VP, Chief Accounting Officer | 29. Mai 2026 S | 14.446 | 0 | 2 | $-305.150 |
| Kevin Carl Pegels | Chief of Global Operations | 5. März 2026 A | 29.038 | 0 | 0 | $0 |
| Everett Cunningham | SVP, Chief Commercial Officer | 5. Juli 2025 F | 41.942 | 0 | 0 | $0 |
| Carissa Rollins | SVP, Chief Information Officer | 5. April 2025 F | 18.447 | 0 | 0 | $0 |
| Charles Dadswell | SVP, General Counsel | 13. September 2024 D | 20.586 | 0 | 0 | $0 |
| Kathryne Gambrell Reeves | SVP, Chief Marketing Officer | 5. März 2024 A | 17.965 | 0 | 0 | $0 |
| Aimee L Hoyt | SVP, Chief People Officer | 7. November 2023 S | 8.314 | 0 | 0 | $0 |
| Susan H Tousi | SVP, Chief Commercial Officer | 5. November 2023 F | 43.743 | 0 | 0 | $0 |
| Alexander Aravanis | SVP, Chief Technology Officer | 5. Juli 2023 F | 12.587 | 0 | 0 | $0 |
| John Edward Frank | Chief Public Affairs Officer | 5. Mai 2023 F | 9.166 | 0 | 0 | $0 |
| Phillip G. Febbo | SVP Chief Medical Officer | 1. März 2023 A | 14.786 | 0 | 0 | $0 |
| Jose Torres | VP, Chief Accounting Officer | 5. Mai 2022 F | 1.748 | 0 | 0 | $0 |
| Karen K Mcginnis | VP, Chief Accounting Officer | 18. Februar 2021 S | 1.538 | 0 | 0 | $0 |
| Robert P Ragusa | SVP, Global Quality & Ops | 17. Februar 2021 M | 9.617 | 0 | 0 | $0 |
| Mostafa Ronaghi | SVP, Entrepreneurial Devlopmt | 10. Dezember 2020 S | 80.162 | 0 | 0 | $0 |
| Mark Van Oene | SVP Chief Commercial Officer | 5. November 2020 F | 16.575 | 0 | 0 | $0 |
| Omead Ostadan | SVP Mktg, Prod & Strat Plan | 11. Mai 2020 S | 17.172 | 0 | 0 | $0 |
| Malcolm Garret Hampton | SVP Clinical Genomics Group | 9. Januar 2020 F | 6.598 | 0 | 0 | $0 |
| Marc Stapley | EVP Strategy & Corp Developmt | 6. Dezember 2018 S | 6.957 | 0 | 0 | $0 |
| Michel Bouchard | Chief Accounting Officer | 6. November 2017 F | 9.538 | 0 | 0 | $0 |
| Christian O Henry | EVP & Chief Commercial Officer | 30. Januar 2017 F | 17.531 | 0 | 0 | $0 |
| Tristan Orpin | EVP Clinical Genomics | 7. November 2016 F | 118.259 | 0 | 0 | $0 |
| Nicholas Naclerio | Sr VP, Corporate Development | 21. März 2016 S | 30.020 | 0 | 0 | $0 |
| Richard Klausner | Sr VP, Chief Medical Officer | 29. Januar 2016 F | 22.847 | 0 | 0 | $0 |
| Gregory Heath | Sr VP & General Manager | 17. Dezember 2013 M | 26.740 | 0 | 0 | $0 |
| Mark L Lewis | Sr VP & General Manager | 1. November 2013 M | 44.837 | 0 | 0 | $0 |
| Matthew L. Posard | Sr VP & General Manager | 30. Mai 2013 M | 30.858 | 0 | 0 | $0 |
| Christian Cabou | Sr VP & General Counsel | 23. April 2013 M | 45.553 | 0 | 0 | $0 |
| Joel Mccomb | Sr VP & General Manager | 28. Januar 2010 F | 6.595 | 0 | 0 | $0 |
| John West | Sr. VP & GM DNA Sequencing | 8. November 2007 M | 82.062 | 0 | 0 | $0 |
| Arthur Holden | Sr VP Corp & Market Dev | 25. Januar 2007 A | · | 0 | 0 | $0 |
| David L Barker | Chief Scientific Officer | 29. November 2005 S | 137.636 | 0 | 0 | $0 |
| Alan Kersey | V.P. & Site Manager | 31. August 2005 S | 48.582 | 0 | 0 | $0 |
| Robert C Kain | Vice President Engineering | 23. August 2005 S | 125.311 | 0 | 0 | $0 |
| Kirk Malloy | V.P. of Customer Solutions | 9. Mai 2005 A | · | 0 | 0 | $0 |
| David C Douglas | Vice President Manufacturing | 2. Mai 2005 S | 0 | 0 | 0 | $0 |
| Scott D Kahn | Chief Information Officer | 6. April 2005 A | · | 0 | 0 | $0 |
| Arnold R Oliphant | VP Scientific Operations | 28. Februar 2005 M | 0 | 0 | 0 | $0 |
| Noemi C Espinosa | VP Intellectual Property | 25. Februar 2005 A | 204.704 | 0 | 0 | $0 |
| Scott B. Ullem | Direktor | 30. September 2026 A | 11.143 | 0 | 0 | $0 |
| Meister, Keith A. | Direktor | 30. September 2026 A | 6.887 | 0 | 93 | $-591.131.765 |
| Daniel Skovronsky | Direktor | 16. Juni 2026 A | 1.674 | 0 | 0 | $0 |
| Scott Gottlieb | Direktor | 21. Mai 2026 A | 14.795 | 2 | 0 | $84.627 |
| David P King | Direktor | 21. Mai 2026 A | 2.072 | 0 | 0 | $0 |
| Susan E Siegel | Direktor | 21. Mai 2026 A | 16.535 | 0 | 0 | $0 |
| Philip W Schiller | Direktor | 21. Mai 2026 A | 22.220 | 0 | 0 | $0 |
| Anna Richo | Direktor | 21. Mai 2026 A | 8.527 | 0 | 0 | $0 |
| Caroline Dorsa | Direktor | 21. Mai 2026 A | 15.754 | 0 | 0 | $0 |
| Frances Arnold | Direktor | 21. Mai 2025 A | 20.907 | 0 | 0 | $0 |
| Gary S Guthart | Direktor | 21. Mai 2025 A | 16.430 | 0 | 0 | $0 |
| Robert S Epstein | Direktor | 21. Mai 2025 A | 22.139 | 0 | 0 | $0 |
| Stephen P Macmillan | Direktor | 16. Mai 2024 A | 4.129 | 0 | 0 | $0 |
| Andrew Teno | Direktor | 26. Mai 2023 A | 1.532 | 0 | 0 | $0 |
| John Wendell Thompson | Direktor | 26. Mai 2022 A | 10.162 | 0 | 0 | $0 |
| Karin Eastham | Direktor | 23. Mai 2019 F | 10.049 | 0 | 0 | $0 |
| Blaine A Bowman | Direktor | 22. Mai 2018 F | 15.946 | 0 | 0 | $0 |
| Daniel Bradbury | Direktor | 25. Mai 2017 M | 15.324 | 0 | 0 | $0 |
| Roy A Whitfield | Direktor | 12. August 2016 M | 2.853 | 0 | 0 | $0 |
| David R Walt | Direktor | 7. April 2016 M | 631.840 | 0 | 0 | $0 |
| William H Rastetter | Direktor | 31. Dezember 2015 A | 8.494 | 0 | 0 | $0 |
| Gerald Moeller | Direktor | 31. März 2015 A | 17.647 | 0 | 0 | $0 |
| Jeff Huber | Direktor | 30. Juli 2014 A | 6.059 | 0 | 0 | $0 |
| Paul C Grint | Direktor | 3. Januar 2013 A | 8.365 | 0 | 0 | $0 |
| Jack Goldstein | Direktor | 10. Mai 2010 D | 2.400 | 0 | 0 | $0 |
| Scott R Greer | Direktor | 20. Mai 2004 A | · | 0 | 0 | $0 |
| Robert Nelsen | Direktor | 3. Februar 2004 J | 11.423 | 0 | 0 | $0 |
| CW VENTURES III LP | 10%-Eigentümer | 12. November 2003 J | 2.865.401 | 0 | 0 | $0 |
| Michael C Sullivan | · | 5. August 2026 A | 4.503 | 0 | 0 | $0 |
| Jay T Flatley | · | 18. Mai 2021 S | 148.933 | 0 | 0 | $0 |
| Paul L Bianchi | · | 18. April 2016 S | 65.660 | 0 | 0 | $0 |
| CABRAL PAULETTE D | · | 20. Januar 2006 G | 2.408 | 0 | 0 | $0 |
| ARCH VENTURE PARTNERS LLC | · | 3. Februar 2004 J | 2.915.298 | 0 | 0 | $0 |
| Clinton Bybee | · | 3. Februar 2004 J | 5.704 | 0 | 0 | $0 |
| Keith Crandell | · | 3. Februar 2004 J | 6.423 | 0 | 0 | $0 |
| Steven Lazarus | · | 3. Februar 2004 J | 2.915.298 | 0 | 0 | $0 |
| ARCH VENTURE FUND III L P | · | 3. Februar 2004 J | 2.915.298 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 114 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PBE · Invesco Exchange-Traded Fund Trust | 6,13% | 95.618 SH | 2. Oktober 2026 | Täglich |
| ARKG · ARK ETF Trust | 4,74% | 359.801 NS | 31. Juli 2026 | N-PORT |
| FMTM · EA Series Trust | 3,50% | 43.050 NS | 31. Juli 2026 | N-PORT |
| UPGD · Invesco Exchange-Traded Fund Trust | 2,71% | 11.691 SH | 2. Oktober 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 2,69% | 10.685 SH | 2. Oktober 2026 | Täglich |
| PTH · Invesco Exchange-Traded Fund Trust | 2,43% | 26.306 SH | 2. Oktober 2026 | Täglich |
| IBB · iShares Trust | 2,25% | 1.153.314 SH | 11. September 2026 | Täglich |
| MTRA · Invesco Actively Managed Exchange-T… | 2,15% | 10.900 SH | 2. Oktober 2026 | Täglich |
| RSPH · Invesco Exchange-Traded Fund Trust | 2,14% | 70.249 SH | 2. Oktober 2026 | Täglich |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 2,09% | 7.028 NS | 31. Juli 2026 | N-PORT |
| THNQ · EXCHANGE TRADED CONCEPTS TRUST | 2,08% | 42.178 NS | 31. Juli 2026 | N-PORT |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 2,01% | 89.222 SH | 2. Oktober 2026 | Täglich |
| ROBO · EXCHANGE TRADED CONCEPTS TRUST | 1,92% | 185.927 NS | 31. Juli 2026 | N-PORT |
| CVAR · ETF Opportunities Trust | 1,86% | 3.891 NS | 31. Juli 2026 | N-PORT |
| ARKK · ARK ETF Trust | 1,45% | 394.332 NS | 31. Juli 2026 | N-PORT |
| PDP · Invesco Exchange-Traded Fund Trust | 0,96% | 53.844 SH | 2. Oktober 2026 | Täglich |
| HFGO · Hartford Funds Exchange-Traded Trust | 0,94% | 9.161 NS | 31. Juli 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,91% | 58.472 NS | 31. Juli 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,87% | 16.623 NS | 31. Juli 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0,82% | 612 NS | 31. Juli 2026 | N-PORT |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,75% | 80.617 SH | 19. August 2026 | Täglich |
| HGRO · ETF Opportunities Trust | 0,74% | 4.557 NS | 31. Juli 2026 | N-PORT |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,73% | 244.355 SH | 19. August 2026 | Täglich |
| IVOV · VANGUARD ADMIRAL FUNDS | 0,70% | 59.759 SH | 19. August 2026 | Täglich |
| MIDU · Direxion Shares ETF Trust | 0,66% | 2.222 NS | 31. Juli 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,49% | 25.195 NS | 31. Juli 2026 | N-PORT |
| IYH · iShares Trust | 0,49% | 88.852 SH | 11. September 2026 | Täglich |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,48% | 10.879 NS | 31. Juli 2026 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0,47% | 12.715 SH | 19. August 2026 | Täglich |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,45% | 12.709 NS | 31. Juli 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,44% | 70.943 NS | 31. Juli 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,42% | 32.057 NS | 31. Juli 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 0,42% | 6.829 NS | 31. Juli 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,39% | 448.145 SH | 19. August 2026 | Täglich |
| VBK · VANGUARD INDEX FUNDS | 0,35% | 951.944 SH | 19. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,30% | 1.736.273 SH | 19. August 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,30% | 3.296.812 SH | 19. August 2026 | Täglich |
| IWS · iShares Trust | 0,30% | 226.531 SH | 11. September 2026 | Täglich |
| FBUF · Fidelity Greenwood Street Trust | 0,29% | 333 NS | 31. Juli 2026 | N-PORT |
| SIZE · iShares Trust | 0,28% | 5.844 SH | 11. September 2026 | Täglich |
| IMCG · iShares Trust | 0,27% | 54.482 SH | 11. September 2026 | Täglich |
| RECS · Columbia ETF Trust I | 0,27% | 77.526 NS | 31. Juli 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,27% | 1.046.460 SH | 19. August 2026 | Täglich |
| RSP · Invesco Exchange-Traded Fund Trust | 0,27% | 952.873 SH | 2. Oktober 2026 | Täglich |
| FHEQ · Fidelity Greenwood Street Trust | 0,26% | 11.829 NS | 31. Juli 2026 | N-PORT |
| FYEE · Fidelity Greenwood Street Trust | 0,25% | 2.609 NS | 31. Juli 2026 | N-PORT |
| FEUS · FlexShares Trust | 0,24% | 1.320 NS | 31. Juli 2026 | N-PORT |
| GLOF · iShares Trust | 0,24% | 2.353 SH | 11. September 2026 | Täglich |
| VFMF · VANGUARD WELLINGTON FUND | 0,23% | 9.219 SH | 19. August 2026 | Täglich |
| IWR · iShares Trust | 0,23% | 622.808 SH | 11. September 2026 | Täglich |
| IMCB · iShares Trust | 0,21% | 17.883 SH | 11. September 2026 | Täglich |
| EUSA · iShares, Inc. | 0,20% | 19.036 SH | 11. September 2026 | Täglich |
| XT · iShares Trust | 0,18% | 33.881 SH | 11. September 2026 | Täglich |
| MTUM · iShares Trust | 0,17% | 206.723 SH | 11. September 2026 | Täglich |
| IMCV · iShares Trust | 0,15% | 8.797 SH | 11. September 2026 | Täglich |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,13% | 3.721.000 | 1. Oktober 2026 | Täglich |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,13% | 3.756 SH | 2. Oktober 2026 | Täglich |
| USXF · iShares Trust | 0,12% | 8.764 SH | 11. September 2026 | Täglich |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,12% | 5.202.000 | 2. Oktober 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,10% | 10.835 SH | 19. August 2026 | Täglich |
| DSI · iShares Trust | 0,08% | 22.547 SH | 11. September 2026 | Täglich |
| IWD · iShares Trust | 0,08% | 338.368 SH | 11. September 2026 | Täglich |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,08% | 13.550 SH | 2. Oktober 2026 | Täglich |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,07% | 105.000 | 1. Oktober 2026 | Täglich |
| DFSU · Dimensional ETF Trust | 0,07% | 7.942 NS | 31. Juli 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,07% | 91.728 SH | 19. August 2026 | Täglich |
| DCOR · Dimensional ETF Trust | 0,07% | 11.084 NS | 31. Juli 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,07% | 24.901 SH | 2. Oktober 2026 | Täglich |
| ESG · FlexShares Trust | 0,07% | 420 NS | 31. Juli 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,06% | 2.322 SH | 2. Oktober 2026 | Täglich |
| ILCG · iShares Trust | 0,06% | 9.644 SH | 11. September 2026 | Täglich |
| PBP · Invesco Exchange-Traded Fund Trust | 0,06% | 899 SH | 2. Oktober 2026 | Täglich |
| ACVF · ETF Opportunities Trust | 0,06% | 454 NS | 31. Juli 2026 | N-PORT |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,06% | 25.587 SH | 2. Oktober 2026 | Täglich |
| USCL · iShares Trust | 0,06% | 7.822 SH | 11. September 2026 | Täglich |
| PHDG · Invesco Actively Managed Exchange-T… | 0,05% | 119 SH | 2. Oktober 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,05% | 34.342 SH | 19. August 2026 | Täglich |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,05% | 21.041 NS | 31. Juli 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,05% | 2.580 NS | 31. Juli 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,05% | 12.653 NS | 31. Juli 2026 | N-PORT |
| ILCB · iShares Trust | 0,05% | 2.951 SH | 11. September 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,05% | 27.243 NS | 31. Juli 2026 | N-PORT |
| IUSV · iShares Trust | 0,04% | 60.729 SH | 11. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,04% | 44.938 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,04% | 102.629 NS | 31. Juli 2026 | N-PORT |
| IUSG · iShares Trust | 0,04% | 71.970 SH | 11. September 2026 | Täglich |
| IYY · iShares Trust | 0,04% | 6.511 SH | 11. September 2026 | Täglich |
| IWB · iShares Trust | 0,04% | 104.858 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,04% | 42.050 SH | 11. September 2026 | Täglich |
| ITOT · iShares Trust | 0,04% | 197.233 SH | 11. September 2026 | Täglich |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,04% | 25.052 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,04% | 12.795 SH | 19. August 2026 | Täglich |
| TOV · EA Series Trust | 0,04% | 563 NS | 31. Juli 2026 | N-PORT |
| TOK · iShares Trust | 0,04% | 421 SH | 11. September 2026 | Täglich |
| URTH · iShares, Inc. | 0,03% | 13.309 SH | 11. September 2026 | Täglich |
| VOXP · Advisors Series Trust | 0,03% | 9 NS | 31. Juli 2026 | N-PORT |
| ILCV · iShares Trust | 0,03% | 2.086 SH | 11. September 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,03% | 4.564.130 SH | 19. August 2026 | Täglich |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,03% | 10.925 SH | 2. Oktober 2026 | Täglich |
| ACWI · iShares Trust | 0,03% | 47.237 SH | 11. September 2026 | Täglich |
| TILT · FlexShares Trust | 0,03% | 3.002 NS | 31. Juli 2026 | N-PORT |
| CRBN · iShares Trust | 0,03% | 1.567 SH | 11. September 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,02% | 128.782 SH | 19. August 2026 | Täglich |
| DYNF · BlackRock ETF Trust | 0,01% | 25.486 SH | 11. September 2026 | Täglich |
| DFUV · Dimensional ETF Trust | 0,01% | 5.274 NS | 31. Juli 2026 | N-PORT |
| IETC · iShares U.S. ETF Trust | 0,00% | 32 SH | 10. September 2026 | Täglich |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15. Juli 2026 | Täglich |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30. Juli 2026 | Täglich |
| IJH · iShares Trust | · | 5.309.264 SH | 11. September 2026 | Täglich |
| IJK · iShares Trust | · | 473.339 SH | 11. September 2026 | Täglich |
| IJJ · iShares Trust | · | 355.271 SH | 31. August 2026 | Täglich |
| XJH · iShares Trust | · | 20.669 SH | 8. September 2026 | Täglich |
ILMN Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 28 Analysten
KAUF
Median-Ziel
$214.00
-21,6%
7 25,0%
Starker Kauf
9 32,1%
Kauf
9 32,1%
Halten
2 7,1%
Verkauf
1 3,6%
Starker Verkauf
12-Monats-Kursziel
20 Analysten · 2026-09-28Mittelwert-Ziel $202.65 -25,8%
Über allen Zielen →
Aktueller Preis $273.04
Tief$113.00
Mittelwert$202.65
Hoch$260.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ILMN | $20.65B | 24.8 | -0.66% | 19.6% | 34.1% | 66.1% |
| TMO | $257.86B | 32.7 | 3.9% | 15.0% | 13.0% | · |
| DHR | $161.82B | 45.3 | 2.9% | 14.7% | 7.1% | 59.1% |
| A | $41.43B | 32.0 | 6.7% | 18.8% | 20.6% | · |
| WAT | $22.62B | 35.3 | 7.0% | 20.3% | 27.2% | · |
| IQV | $38.23B | 28.8 | 5.9% | 8.3% | 21.6% | · |
| MTD | $28.38B | 33.2 | 4.0% | 21.6% | -615.5% | 59.4% |
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | · |
| RVTY | $10.86B | 46.7 | 3.7% | 8.5% | 3.3% | · |
| TEM | · | -41.9 | 83.4% | -19.3% | -61.2% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Illumina and Everpure to Join S&P 500 in September Rebalancing: What it Means for Investors
Yahoo Finance · 3 Wochen, 4 Tage vor
Is Grail (GRAL) Stock a Buy, Sell, or Hold at Under $70?
Nasdaq · 2 Monate vor
Ilhan Omar beschuldigt, 1,4 Mio. US-Dollar an gemeinnützige Organisation mit somalischem Restaurant als Adresse leiten zu wollen
ZeroHedge · 5 Monate, 1 Woche vor
Handelssignale Aktuelle Kauf-/Verkaufssignale mit Einstiegspreis und Risiko-Ertrags-Verhältnis
Derzeit kein offenes Signal – keine Karte ist ausgefüllt, und das ist ehrlich.
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Jul 31, 2026